Epic Biosonics

Epic Biosonics Inc. is a developer of therapeutic devices, specifically focusing on cochlear prostheses to address deafness. Based in Victoria, British Columbia, Canada, the company operates in the medical device manufacturing industry.

The core of its technology is the patented EpicCircuit, a photolithographic batch fabrication process used to create neurostimulation electrodes. This technology allows for the production of fluoropolymer encapsulated electrode arrays using conductive elements like platinum and gold. The process is designed to enable the creation of smaller, thinner, and more complex devices compared to traditional hand fabrication methods, potentially speeding up prototyping and reducing manufacturing costs. The company has conducted long-term animal implant studies to test its electrode arrays, which have shown no evidence of tissue adhesion, inflammation, or infection after more than two years.

Epic Biosonics primarily serves the medical technology market. It has a significant partnership with the Austrian cochlear implant manufacturer, MED-EL Medical Electronics GmbH, which holds an exclusive, worldwide license to the EpicCircuit technology for the field of hearing implants. Keywords: neurostimulation electrodes, cochlear prosthesis, therapeutic devices, hearing implants, medical device, EpicCircuit technology, electrode arrays, implantable microphones, deafness solutions, fluoropolymer encapsulated electrodes